Incyte (INCY) News Today $65.30 +1.49 (+2.34%) As of 05/20/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INCY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Incyte Q1 Earnings TranscriptMay 20 at 7:15 AM | marketbeat.comTema Etfs LLC Buys Shares of 30,378 Incyte Co. (NASDAQ:INCY)Tema Etfs LLC bought a new stake in Incyte Co. (NASDAQ:INCY - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 30,378 shares of the biopharmaceutical company's stock, valued at approximaMay 20 at 6:16 AM | marketbeat.comSiemens Fonds Invest GmbH Acquires Shares of 5,806 Incyte Co. (NASDAQ:INCY)Siemens Fonds Invest GmbH bought a new position in shares of Incyte Co. (NASDAQ:INCY - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 5,806 shares of the biopharmaceutical company's stock, valuedMay 20 at 5:57 AM | marketbeat.comIncyte Co. (NASDAQ:INCY) Receives Consensus Rating of "Hold" from AnalystsIncyte Co. (NASDAQ:INCY - Get Free Report) has received an average recommendation of "Hold" from the eighteen analysts that are covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, thirteen have issued a hold recommendation aMay 20 at 2:35 AM | marketbeat.comIs Wall Street Bullish or Bearish on Incyte Stock?May 19 at 11:59 AM | msn.comFDA approves Incyte’s retifanlimab combo for SCAC treatmentMay 19 at 11:59 AM | finance.yahoo.comShell Asset Management Co. Cuts Stock Holdings in Incyte Co. (NASDAQ:INCY)Shell Asset Management Co. lowered its stake in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 41.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 26,447 shares of the biopharmaceutical company's stock after selliMay 19 at 6:35 AM | marketbeat.comIncyte Co. (NASDAQ:INCY) Stock Holdings Lessened by Rafferty Asset Management LLCRafferty Asset Management LLC lowered its position in Incyte Co. (NASDAQ:INCY - Free Report) by 28.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 203,319 shares of the biopharmaceutical company's stock after selling 79,302 shares during the pMay 19 at 6:05 AM | marketbeat.comJanus Henderson Group PLC Purchases 26,761 Shares of Incyte Co. (NASDAQ:INCY)Janus Henderson Group PLC grew its position in Incyte Co. (NASDAQ:INCY - Free Report) by 15.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 197,890 shares of the biopharmaceutical company's stock after buying an additional 26,761May 19 at 4:35 AM | marketbeat.comBalyasny Asset Management L.P. Lowers Stake in Incyte Co. (NASDAQ:INCY)Balyasny Asset Management L.P. reduced its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 79.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,314 shares of the biopharmaceutical compMay 19 at 3:48 AM | marketbeat.comRedwood Investment Management LLC Takes $1.44 Million Position in Incyte Co. (NASDAQ:INCY)Redwood Investment Management LLC acquired a new stake in shares of Incyte Co. (NASDAQ:INCY - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 20,788 shares of the biopharmaceutical company's stock, valued at apprMay 18 at 6:16 AM | marketbeat.comOMERS ADMINISTRATION Corp Cuts Holdings in Incyte Co. (NASDAQ:INCY)OMERS ADMINISTRATION Corp trimmed its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 26.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 28,487 shares of the biopharmaceutical company's stock aMay 18 at 4:56 AM | marketbeat.comPoint72 Hong Kong Ltd Increases Holdings in Incyte Co. (NASDAQ:INCY)Point72 Hong Kong Ltd grew its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 2,274.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 69,965 shares of the biopharmaceutical company's stock after buying anMay 17, 2025 | marketbeat.comMan Group plc Has $50.36 Million Position in Incyte Co. (NASDAQ:INCY)Man Group plc reduced its stake in Incyte Co. (NASDAQ:INCY - Free Report) by 9.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 729,037 shares of the biopharmaceutical company's stock after selling 75,915 shares during the quarter. Man Group plcMay 17, 2025 | marketbeat.comIncyte Co. (NASDAQ:INCY) Shares Acquired by Lazard Asset Management LLCLazard Asset Management LLC boosted its position in Incyte Co. (NASDAQ:INCY - Free Report) by 123.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 147,172 shares of the biopharmaceutical companMay 17, 2025 | marketbeat.comCaptrust Financial Advisors Has $1.39 Million Position in Incyte Co. (NASDAQ:INCY)Captrust Financial Advisors raised its stake in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 248.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 20,166 shares of the biopharmaceutical company's stock after buying an aMay 17, 2025 | marketbeat.comBank of America Corp DE Has $45.44 Million Stock Position in Incyte Co. (NASDAQ:INCY)Bank of America Corp DE lowered its position in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 24.8% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 657,806 shares of the biopharmaceutical company's stoMay 17, 2025 | marketbeat.comLMR Partners LLP Lowers Stock Holdings in Incyte Co. (NASDAQ:INCY)LMR Partners LLP trimmed its position in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 93.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 11,049 shares of the biopharmaceutical company's stock after selling 150,43May 16, 2025 | marketbeat.comJefferies Financial Group Inc. Makes New Investment in Incyte Co. (NASDAQ:INCY)Jefferies Financial Group Inc. bought a new position in shares of Incyte Co. (NASDAQ:INCY - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 42,777 shares of the biopharmaceutical company's stoMay 16, 2025 | marketbeat.comGotham Asset Management LLC Has $5.34 Million Stock Holdings in Incyte Co. (NASDAQ:INCY)Gotham Asset Management LLC boosted its position in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 18.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 77,313 shares of the biopharmaceutical company's stock after buyinMay 16, 2025 | marketbeat.comCresset Asset Management LLC Lowers Stock Holdings in Incyte Co. (NASDAQ:INCY)Cresset Asset Management LLC trimmed its position in Incyte Co. (NASDAQ:INCY - Free Report) by 49.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,489 shares of the biopharmaceuMay 16, 2025 | marketbeat.comIncyte Announces FDA Approval of Zynyz® (retifanlimab-dlwr) Making it the First and Only Approved First-Line Treatment for Advanced Anal Cancer Patients in the United StatesMay 15, 2025 | businesswire.comInvestment Management Corp of Ontario Has $1.27 Million Stock Holdings in Incyte Co. (NASDAQ:INCY)Investment Management Corp of Ontario lessened its stake in Incyte Co. (NASDAQ:INCY - Free Report) by 31.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,356 shares of the biopharmaceutical company's stock after sellingMay 15, 2025 | marketbeat.comAmeriprise Financial Inc. Has $39.16 Million Holdings in Incyte Co. (NASDAQ:INCY)Ameriprise Financial Inc. lessened its stake in Incyte Co. (NASDAQ:INCY - Free Report) by 23.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 566,990 shares of the biopharmaceutical company's stock after selling 176,002 shaMay 15, 2025 | marketbeat.comMercer Global Advisors Inc. ADV Increases Position in Incyte Co. (NASDAQ:INCY)Mercer Global Advisors Inc. ADV grew its position in Incyte Co. (NASDAQ:INCY - Free Report) by 131.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,624 shares of the biopharmaceutical company's stock aMay 15, 2025 | marketbeat.comIncyte Corporation (INCY): Among Small-Cap Healthcare Stocks Hedge Funds Are BuyingMay 14, 2025 | msn.comIncyte, Novartis Pharma Reach Settlement Over Jakafi RoyaltiesMay 14, 2025 | marketwatch.comIncyte and Novartis settle royalties dispute related to JakafiMay 14, 2025 | msn.comIncyte Corporation (INCY) Reaches Settlement with Novartis Over Royalty DisputeMay 14, 2025 | gurufocus.comIncyte (INCY) Reaches $280M Settlement with Novartis Over Jakafi RoyaltiesMay 14, 2025 | gurufocus.comIncyte Settles Royalty Dispute with NovartisMay 14, 2025 | tipranks.comIncyte Co. (NASDAQ:INCY) Shares Sold by Invenomic Capital Management LPInvenomic Capital Management LP reduced its position in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 13.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 76,771 shares of thMay 14, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Has $61.59 Million Position in Incyte Co. (NASDAQ:INCY)Jacobs Levy Equity Management Inc. raised its position in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 861.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 891,659 shares of the biopharmaceutical cMay 14, 2025 | marketbeat.comDeutsche Bank AG Increases Stock Holdings in Incyte Co. (NASDAQ:INCY)Deutsche Bank AG boosted its position in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 22.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,176,137 shares of the biopharmaceuticalMay 14, 2025 | marketbeat.comEnsign Peak Advisors Inc Buys 67,412 Shares of Incyte Co. (NASDAQ:INCY)Ensign Peak Advisors Inc boosted its stake in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 21.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 378,060 shares of the biopharmaceutical company's stock after acquiring an additional 6May 13, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Decreases Stock Holdings in Incyte Co. (NASDAQ:INCY)D. E. Shaw & Co. Inc. lowered its stake in Incyte Co. (NASDAQ:INCY - Free Report) by 48.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 576,540 shares of the biopharmaceutical company's stock after selling 532,033 sharesMay 13, 2025 | marketbeat.comDZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Sells 35,566 Shares of Incyte Co. (NASDAQ:INCY)DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main lowered its stake in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 43.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 45,945 shares of the biopharmaceutical company's stock afterMay 13, 2025 | marketbeat.comAlgert Global LLC Takes Position in Incyte Co. (NASDAQ:INCY)Algert Global LLC purchased a new position in shares of Incyte Co. (NASDAQ:INCY - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 46,250 shares of the biopharmaceutical company's stock, valued at approximately $3,194,0May 10, 2025 | marketbeat.comAxa S.A. Decreases Stake in Incyte Co. (NASDAQ:INCY)Axa S.A. cut its position in Incyte Co. (NASDAQ:INCY - Free Report) by 26.3% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 83,719 shares of the biopharmaceutical company's stock after selling 29,805 sharMay 9, 2025 | marketbeat.comIncyte to Present at 2025 BofA Securities Health Care ConferenceMay 8, 2025 | msn.comCubist Systematic Strategies LLC Acquires 192,004 Shares of Incyte Co. (NASDAQ:INCY)Cubist Systematic Strategies LLC lifted its stake in Incyte Co. (NASDAQ:INCY - Free Report) by 270.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 263,019 shares of the biopharmaceutical company's stock after aMay 8, 2025 | marketbeat.comBrevan Howard Capital Management LP Buys 16,164 Shares of Incyte Co. (NASDAQ:INCY)Brevan Howard Capital Management LP increased its stake in Incyte Co. (NASDAQ:INCY - Free Report) by 43.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 52,953 shares of the biopharmaceutical company's stock after purchasing an additional 16,16May 8, 2025 | marketbeat.comIncyte Reports Strong Q1 2025 Financial Results and Pipeline ProgressMay 7, 2025 | msn.comIncyte Co. (NASDAQ:INCY) Shares Acquired by Bellevue Group AGBellevue Group AG increased its stake in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 0.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,157,478 shares of the biopharmaceutical company's stock after purchasingMay 6, 2025 | marketbeat.comFreestone Grove Partners LP Takes Position in Incyte Co. (NASDAQ:INCY)Freestone Grove Partners LP bought a new position in Incyte Co. (NASDAQ:INCY - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 6,462 shares of the biopharmaceutical compaMay 6, 2025 | marketbeat.comNorthern Trust Corp Purchases 150,672 Shares of Incyte Co. (NASDAQ:INCY)Northern Trust Corp boosted its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 9.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,696,123 shares of the biopharmaceutical company's stock after buying an additional 150,672 shares duriMay 6, 2025 | marketbeat.comThe Manufacturers Life Insurance Company Purchases 19,334 Shares of Incyte Co. (NASDAQ:INCY)The Manufacturers Life Insurance Company boosted its position in Incyte Co. (NASDAQ:INCY - Free Report) by 11.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 184,871 shares of the biopharmaceutical company's stock after acquiring an additional 19,3May 6, 2025 | marketbeat.comLabcorp's latest deal targets Incyte Diagnostics, enhancing oncology testing in Pacific NorthwestMay 5, 2025 | bizjournals.comMeiji Yasuda Life Insurance Co Acquires 6,533 Shares of Incyte Co. (NASDAQ:INCY)Meiji Yasuda Life Insurance Co raised its holdings in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 90.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 13,786 shares of the biopharmaceutical company's stock aftMay 5, 2025 | marketbeat.comCaisse DE Depot ET Placement DU Quebec Increases Stock Position in Incyte Co. (NASDAQ:INCY)Caisse DE Depot ET Placement DU Quebec raised its position in shares of Incyte Co. (NASDAQ:INCY - Free Report) by 8,220.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 416,202 shares of the biopharmaceuticalMay 5, 2025 | marketbeat.com Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Email Address INCY Media Mentions By Week INCY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INCY News Sentiment▼1.110.65▲Average Medical News Sentiment INCY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INCY Articles This Week▼3415▲INCY Articles Average Week Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alnylam Pharmaceuticals News Today Biogen News Today United Therapeutics News Today Exelixis News Today Neurocrine Biosciences News Today BioMarin Pharmaceutical News Today Exact Sciences News Today Repligen News Today Halozyme Therapeutics News Today Madrigal Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INCY) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Incyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INCY Stock Free INCY Stock Alerts